Whole body hyperthermia associated with beta-carotene supplementation in patients with AIDS
- PMID: 7579006
- DOI: 10.1016/0753-3322(96)82633-3
Whole body hyperthermia associated with beta-carotene supplementation in patients with AIDS
Abstract
The objective of this work was to check possible additive beneficial effects of whole body hyperthermia (WBH) associated with beta-carotene (BC) supplementation in patients with AIDS. In a pilot study, 10 HIV positive patients, (8 with AIDS and 2 with AIDS related complex, ARC), after AZT or DDI discontinuation, were first treated with one single session of WBH applied with a non-invasive procedure at 42 degrees C core temperature for one hour, and subsequently supplemented with BC 120 mg daily continuously. All patients well tolerated the non-invasive WBH as well as the high dose BC supplementation. Apart from one patient who died after 4 months, all the others underwent an HIV burden diminution, clinical improvement and amelioration of laboratory data, along with an subjective improvement of their life quality. With reference to control groups, namely (a) only WBH applied with extracorporeal procedure to 31 AIDS patients, and (b) only BC supplementation at high dosage applied to 64 ARC patients, the combined physical and BC supplemental treatments clearly showed a better and longer lasting response.
Similar articles
-
Short communication: possible activity of beta-carotene in patients with the AIDS related complex. A pilot study.Med Oncol Tumor Pharmacother. 1992;9(3):151-3. doi: 10.1007/BF02987747. Med Oncol Tumor Pharmacother. 1992. PMID: 1364129 Clinical Trial.
-
Therapeutic hyperthermia in cancer and AIDS: an updated survey.J Environ Pathol Toxicol Oncol. 1996;15(2-4):289-97. J Environ Pathol Toxicol Oncol. 1996. PMID: 9216824 Review.
-
Carotenoids in cancer, mastalgia, and AIDS: prevention and treatment--an overview.J Environ Pathol Toxicol Oncol. 1996;15(2-4):89-95. J Environ Pathol Toxicol Oncol. 1996. PMID: 9216791 Review.
-
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome.Eur J Clin Nutr. 2006 Nov;60(11):1266-76. doi: 10.1038/sj.ejcn.1602447. Epub 2006 May 24. Eur J Clin Nutr. 2006. PMID: 16721396 Clinical Trial.
-
The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene.Am J Clin Nutr. 1996 Jul;64(1):101-7. doi: 10.1093/ajcn/64.1.101. Am J Clin Nutr. 1996. PMID: 8669404 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical